Product Information
BETAMETHASONE VALER 0.12% FOAM is a generic product labeled by Taro Pharmaceuticals U.S.A. Inc., priced at $0.6316 per GM under NDC 51672418803. Its NADAC has been published 473 times since Sep 13, 2017.
FDA first approved this application on May 24, 2017. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
1.2 mg/g
Manufacturer
Taro Pharmaceuticals U.S.A. Inc.NDC
51672418803
Classification
Generic
Dosage Form
AEROSOL, FOAM
Route
TOPICAL
Effective Date
9/23/2026
Active Ingredients
BETAMETHASONE VALERATEApproval Type
Generic (ANDA)
FDA Application
ANDA208204FDA Approved
5/24/2017
TE Code
AB
On Market Since
5/24/2017
Pharmacological Classes
Price Statistics
The NADAC for BETAMETHASONE VALER 0.12% FOAM has been published 473 times since Sep 13, 2017, and over the history we have for it it has declined 87.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.6316 per GM |
|---|---|
| All-time high | $5.1028 (Nov 15, 2017) |
| All-time low | $0.5046 (Jan 17, 2024) |
| 52-week high | $0.7252 |
| 52-week low | $0.6316 |
| Median price | $1.1587 |
| Average price | $1.7285 |
| Largest weekly change | +89.1% (Feb 23, 2022) |
| Weeks tracked | 473 |
| Tracking since | Sep 13, 2017 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Taro Pharmaceuticals U.S.A. Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Betamethasone Valerate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Corticosteroid class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of BETAMETHASONE VALER 0.12% FOAM?
The current National Average Drug Acquisition Cost (NADAC) for BETAMETHASONE VALER 0.12% FOAM, manufactured by Taro Pharmaceuticals U.S.A. Inc., is $0.6316 per GM (NDC 51672418803), effective Sep 30, 2026.
How has the price of BETAMETHASONE VALER 0.12% FOAM changed over time?
Over the history we have for it, the NADAC for BETAMETHASONE VALER 0.12% FOAM has declined 87.6%. It has been tracked across 473 weekly CMS publications since Sep 13, 2017.
What are the highest and lowest recorded NADAC prices for BETAMETHASONE VALER 0.12% FOAM?
Since Sep 13, 2017, the NADAC for BETAMETHASONE VALER 0.12% FOAM has ranged from a low of $0.5046 (Jan 17, 2024) to a high of $5.1028 (Nov 15, 2017), with a median of $1.1587 per GM.
Are there cheaper alternatives to BETAMETHASONE VALER 0.12% FOAM?
2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as BETAMETHASONE VALER 0.12% FOAM in a comparable dosage form, but none are currently priced below it.
Who manufactures BETAMETHASONE VALER 0.12% FOAM?
BETAMETHASONE VALER 0.12% FOAM (NDC 51672418803) is labeled by Taro Pharmaceuticals U.S.A. Inc., and CMS classifies it as a generic product.